Organic Nanocarriers for Bevacizumab Delivery: An Overview of Development, Characterization and Applications

Bevacizumab (BCZ) is a recombinant humanized monoclonal antibody against the vascular endothelial growth factor, which is involved in the angiogenesis process. Pathologic angiogenesis is observed in several diseases including ophthalmic disorders and cancer. The multiple administrations of BCZ can c...

Descripción completa

Detalles Bibliográficos
Autores principales: Alves, Aline de Cristo Soares, Bruinsmann, Franciele Aline, Guterres, Silvia Stanisçuaski, Pohlmann, Adriana Raffin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305806/
https://www.ncbi.nlm.nih.gov/pubmed/34299401
http://dx.doi.org/10.3390/molecules26144127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305806/
https://www.ncbi.nlm.nih.gov/pubmed/34299401
http://dx.doi.org/10.3390/molecules26144127

Ejemplares similares